SmithKline Beecham Clinical Laboratories
This article was originally published in The Gray Sheet
Executive Summary
Introduces a polymerase chain reaction-based chlamydia laboratory testing service. The firm is promoting the test for use by men, noting that it enables testing with urine samples "instead of the old painful method of urethral swabbing." The firm says the test will cost about $100 and will be able to provide results within 48 hours of the laboratory's receipt of a sample. The company, which licenses PCR technology from Roche, currently offers PCR laboratory testing for HIV and tuberculosis